Uptake of a colorectal cancer screening blood test in people with elevated risk for cancer who cannot or will not complete a faecal occult blood test
- 1 September 2018
- journal article
- research article
- Published by Wolters Kluwer Health in European Journal Of Cancer Prevention
- Vol. 27 (5) , 425-432
Abstract
Participation rates in colorectal cancer (CRC) screening programmes using faecal occult blood tests (FOBTs) are low. Nonparticipation is commonly attributed to psychosocial factors, but some medical conditions also prevent screening. These barriers might be partially overcome if a blood test for CRC screening was available. This study determined whether people who had always declined screening by FOBT would participate if offered a blood test. An audit of registrants within a personalized CRC screening programme was undertaken to determine the reasons for regular nonparticipation in FOBT. Consistent nonparticipants (n=240) were randomly selected and invited for CRC screening with a blood test. Demographic characteristics and the reasons for prior FOBT nonparticipation were collected by means of a questionnaire. Nonparticipation in the screening programme could be classified as either behavioural (8.6%), with consistent noncompliance, or due to medical contraindications (8.5%), which included chronic rectal bleeding, being deemed unsuitable by a health professional, and needing personal assistance. Blood test uptake was 25%, with participation in the medical contraindications group greater than that in the behavioural group (43 vs. 12%, P0.05). There is a subgroup of the community who have medical reasons for nonparticipation in CRC screening with FOBT but will participate if offered a blood test. The option of a blood test does not, however, improve uptake in those who admit to behavioural reasons for noncompliance with screening.Keywords
This publication has 22 references indexed in Scilit:
- The prevalence of medical reasons for non-participation in the Scottish breast and bowel cancer screening programmesJournal of Medical Screening, 2015
- Improving compliance to colorectal cancer screening using blood and stool based tests in patients refusing screening colonoscopy in GermanyBMC Gastroenterology, 2014
- Interval Fecal Immunochemical Testing in a Colonoscopic Surveillance Program Speeds Detection of Colorectal NeoplasiaGastroenterology, 2010
- Psychosocial Variables Associated with Colorectal Cancer Screening in South AustraliaInternational Journal of Behavioral Medicine, 2010
- Random Comparison of Guaiac and Immunochemical Fecal Occult Blood Tests for Colorectal Cancer in a Screening PopulationGastroenterology, 2008
- Achieving long-term compliance with colonoscopic surveillance guidelines for patients at increased risk of colorectal cancer in AustraliaInternational Journal Of Clinical Practice, 2007
- Cost-effectiveness model for colon cancer screeningGastroenterology, 1995
- Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult BloodNew England Journal of Medicine, 1993
- Prevention of colorectal cancer by once-only sigmoidoscopyThe Lancet, 1993
- CONTROLLED TRIAL OF FAECAL OCCULT BLOOD TESTING IN THE DETECTION OF COLORECTAL CANCERThe Lancet, 1983